Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Science and Technology Daily: China's Fertile Grounds for Innovation 2024-06-24 21:41
Bota Bio's Biomanufacturing Technology is Commercialized at NHU with A Successful Strategic Partnership Established 2024-06-24 21:00
TiumBio Presents Promising Clinical Data from Phase 1 of its Hemophilia Treatment Candidate TU7710 at ISTH 2024 2024-06-24 20:00
iRegene Receives IND approval from U.S. FDA to Start Clinical Trial for Parkinson's Disease 2024-06-24 20:00
Keymed Biosciences Announces Safety and Efficacy Results of CM313 for Primary Immune Thrombocytopenia Published in NEJM 2024-06-20 14:51
GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group 2024-06-20 08:44
CMT Research Foundation Invests in ReviR Therapeutics Research to Pioneer Small Molecule Therapeutics for CMT1A 2024-06-19 21:00
Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma 2024-06-19 19:30
GenFleet Receives IND Approval from China's NMPA for GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, in a Phase I/II Clinical Trial Treating Advanced Solid Tumor Patients with KRAS G12D Mutation 2024-06-19 19:00
Tang Prize in Biopharmaceutical Science Honoring Three Scientists 2024-06-19 12:15
YolTech and KACTUS Join Forces to Propel Innovative DNA editing system in Greater China 2024-06-19 09:00
Bloomage Leads Discussions of Hyaluronic Acid Development at 2nd Hyaluronic Acid Industry Conference 2024-06-18 22:00
Singleron Biotechnologies partners with the Human Cell Atlas (HCA) to enhance access to single cell analysis globally 2024-06-18 21:00
ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with Asieris Pharmaceuticals 2024-06-17 22:00
Noul Participates in a Malaria Project Initiated by U.S. CDC with Kenya Medical Research Institute 2024-06-17 21:00
Peijia Medical Reports Audited 2023 Financial Results and Resumes Trading 2024-06-17 20:30
IASO Bio Presented New Data of FUCASO® (Equecabtagene Autoleucel) for the Treatment of High-risk Newly Diagnosed Multiple Myeloma in Oral Presentation at EHA 2024 2024-06-15 22:30
CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024 2024-06-15 20:50
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement 2024-06-13 20:30
Latest Updates of Viva Biotech's Portfolio Companies 2024-06-12 19:51
1 13 14 15 16 17 222